CSI Market
Sign In | Register

Gain Therapeutics inc (GANX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GANX Annual Balance Sheets →
Balance sheet patterns shown here provide context for understanding Gain Therapeutics inc's financial stability and long-term positioning.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent13.08
Cash & Short-term Investments13.00
Notes Receivable, Current0.82
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.00
Total Current Assets14.97
Equipment/Property/Plant Net0.21
Other Assets, Noncurrent1.30
Deferred Income Taxes And Other Tax Receivable Current0.23
Operating Lease Right Of Use Asset0.30
Restricted Cash Noncurrent0.04
Total Assets15.42
Liabilities
Accounts Payable, Current AC1.22
Accrued Liabilities, Current1.20
Long-term Debt, Current Maturities LO0.12
Other Liabilities, Current0.66
Taxes Payable, Current, Total0.23
Total Current Liabilities3.43
Long-term debt0.34
Total Long-term Debt0.34
Defined Benefit Pension Plan, Liabilities, Noncurrent PE0.32
Other liabilities, Noncurrent0.03
Operating Lease Liability Current0.12
Deferred Income Current-
Operating Lease Liability Noncurrent0.18
Total Liabilities4.13
Stockholders' Equity
Income Loss For Period-5.61
Common Stock Value0.00
Additional Paid In Capital Common Stock121.92
Retained Earnings / Accumulated Deficit-111.64
Accumulated Other Comprehensive Income1.00
Other Equity1.00
Common Stockholder's Equity11.29
Total Stockholder's Equity11.29
Liabilities & Stockholder's Equity15.42
4 historic quarters locked

Sign in to unlock the full Gain Therapeutics inc balance sheet history.

Sign In Create Free Account

About Gain Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-094048

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.